Galectin‐9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation

OBJECTIVE: Objective evaluation of disease activity is challenging in patients with juvenile dermatomyositis (DM) due to a lack of reliable biomarkers, but it is crucial to avoid both under‐ and overtreatment of patients. Recently, we identified 2 proteins, galectin‐9 and CXCL10, whose levels are hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wienke, Judith, Bellutti Enders, Felicitas, Lim, Johan, Mertens, Jorre S., van den Hoogen, Luuk L., Wijngaarde, Camiel A., Yeo, Joo Guan, Meyer, Alain, Otten, Henny G., Fritsch‐Stork, Ruth D. E., Kamphuis, Sylvia S. M., Hoppenreijs, Esther P. A. H., Armbrust, Wineke, van den Berg, J. Merlijn, Hissink Muller, Petra C. E., Tekstra, Janneke, Hoogendijk, Jessica E., Deakin, Claire T., de Jager, Wilco, van Roon, Joël A. G., van der Pol, W. Ludo, Nistala, Kiran, Pilkington, Clarissa, de Visser, Marianne, Arkachaisri, Thaschawee, Radstake, Timothy R. D. J., van der Kooi, Anneke J., Nierkens, Stefan, Wedderburn, Lucy R., van Royen‐Kerkhof, Annet, van Wijk, Femke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Pediatric Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973145/
https://www.ncbi.nlm.nih.gov/pubmed/30861625
http://dx.doi.org/10.1002/art.40881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973145/
https://www.ncbi.nlm.nih.gov/pubmed/30861625
http://dx.doi.org/10.1002/art.40881

Ejemplares similares